| 48.8809 0.87 (1.81%) | 11-11 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 57.16 |
1-year : | 66.76 |
| Resists | First : | 48.93 |
Second : | 57.16 |
| Pivot price | 47.54 |
|||
| Supports | First : | 46.17 |
Second : | 44.47 |
| MAs | MA(5) : | 47.81 |
MA(20) : | 47.29 |
| MA(100) : | 41.39 |
MA(250) : | 40.79 |
|
| MACD | MACD : | 1 |
Signal : | 1.1  |
| %K %D | K(14,3) : | 71.2 |
D(3) : | 62.1 |
| RSI | RSI(14): 69.2 |
|||
| 52-week | High : | 48.93 | Low : | 33.56 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ PTH ] has closed below upper band by 0.3%. Bollinger Bands are 1.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 48.99 - 49.17 | 49.17 - 49.39 |
| Low: | 47.65 - 47.85 | 47.85 - 48.09 |
| Close: | 48.5 - 48.83 | 48.83 - 49.21 |
PTH provides an alternate take on US healthcare firms, with a lot of emphasis on the biotech and research sector compared to our more pharma and provider-focused neutral benchmark. PTH has been around for a while but changed indexes in 2014 to adopt a momentum-weighted Dorsey-Wright relative strength index. This has contributed to the fund's sharp pivot away from neutral segment exposure toward growth sectors. Unsurprisingly, the fund tilts small and carries considerably more risk. The fund selects the top, at least 30 stocks, with the highest momentum scores in the healthcare space. The fund uses a full replication indexing strategy. Overall, PTH offers a different, growth-focused take on healthcare. Investors should consider all-in costs of holding the fund. The fund is reconstituted and rebalanced quarterly. Prior to August 28, 2023, the ETF's name was Invesco DWA Healthcare Momentum ETF.
Thu, 18 Sep 2025
Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs - Benzinga
Mon, 10 Mar 2025
PTH: A Health Care Headache Worth Selling (NASDAQ:PTH) - Seeking Alpha
Fri, 20 Dec 2024
Unwrapping 5 ETF Surprises From Secret Santa for Christmas - Nasdaq
Fri, 31 May 2024
Finding Opportunity in Unloved Healthcare ETFs - ETF Trends
Fri, 01 Sep 2023
This Week in ETFs: Invesco Makes Changes to 35 Funds - ETF Trends
Wed, 17 Feb 2021
Up 85%, 'PTH' Holds the Right Healthcare Approaches - ETF Database
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|